Branchburg, NJ, United States of America

Susan M Chesson

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Aventis Pharmaceuticals Inc.. Active years: 2000.


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2000

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Susan M. Chesson

Introduction

Susan M. Chesson is a notable inventor based in Branchburg, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as acetylcholinesterase inhibitors and analgesics. Her work is crucial for addressing memory dysfunction and pain management.

Latest Patents

Susan M. Chesson holds 1 patent for her invention titled "Isatin derivatives as acetylcholinesterase inhibitors and analgesics." This patent relates to compounds that are useful for treating memory dysfunction characterized by decreased cholinergic function, as well as for providing analgesia. The pharmaceutical compositions containing these compounds and the methods for making and using them are essential advancements in medical science.

Career Highlights

Chesson is currently associated with Aventis Pharmaceuticals Inc., where she continues to innovate and contribute to the pharmaceutical industry. Her expertise and dedication have positioned her as a valuable asset in her field.

Collaborations

Throughout her career, Susan has collaborated with esteemed colleagues such as Abdul Ezaz Mutlib and Stephen J. Shimshock. These partnerships have fostered an environment of innovation and have led to the development of impactful pharmaceutical solutions.

Conclusion

Susan M. Chesson's work exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions are vital for advancing treatments that improve the quality of life for many individuals.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…